MALP-2,a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?

Abstract

Although some activities of LPS are shared by other bacterial components, for half a century LPS has been regarded as unique in displaying many pathophysiological activities. Here we report on a synthetic lipopeptide, MALP-2 from Mycoplasma fermentans , which expresses potent endotoxin-like activity and whose lethal toxicity is comparable to that of LPS. With the exception of the Limulus lysate gelation test, in which MALP-2 was approximately 1000-fold less active than LPS, the synthetic lipopeptide induced all activities tested for, and in most cases to an extent comparable to that of LPS. Unlike LPS, the biological activities of MALP-2 were expressed both in LPSresponder and in LPS-non-responder mice (BALB/c/l, C57BL10/ScCr), indicating that MALP-2 signaling, unlike that of LPS, is not transduced via the Toll-like receptor (Tlr) 4 protein. MALP-2 expressed no toxicity in normal or sensitized Tlr2 knockout (Tlr2^{— /—}) mice indicating that its toxic activity is induced via Tlr2 signaling. The phenomenology of the lethal shock induced by MALP-2 in normal or sensitized mice, i.e. the kinetics of its development and symptoms of illness exhibited by the treated animals, was very reminiscent of the lethal shock induced by LPS.

References

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085—2088.

Brade H , Opal SM , Vogel SN , Morrison DC. (eds) Endotoxin in Health and Disease. New York Marcel Dekker , 1999.

Henderson B. , Poole S. , Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60: 316—341.

Chambaud I. , Wròblewski H. , Blanchard A. Interactions between Mycoplasma lipoproteins and the host immune system. Trends Microbiol 1999; 7: 493—499.

Melchers F. , Braun V. , Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. Exp Med 1975; 142: 473—482.

Mühlradt PF , Kiess M. , Meyer H. , Süssmuth R. , Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997; 185: 1951—1958.

Takeuchi O. , Kaufmann A. , Grote K. et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164: 554—557.

Deiters U. , Mühlradt PF Mycoplasmal lipopeptide MALP-2 induces the chemoatractant proteins MIP-1α, MCP-1, and MIP-2 and promotes leucocyte infiltration in mice. Infect Immun 1999; 67: 3390—3398.

Freudenberg MA , Merlin T. , Sing A. , Salamao R. , Galanos C. Bacteria-induced hypersensitivity to endotoxin. In: Brade H , Opal SM , Vogel SN , Morrison DC. (eds) Endotoxin in Health and Disease. New York : Marcel Dekker Inc, 1999; 719—734.

10.

DeLeo AB , Shiku H. , Takahashi T. , John M. , Old LJ Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth-A sarcoma. J Exp Med 1977; 146: 720—734.

11.

Galanos C. , Freudenberg MA , Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76: 5939—5943.

12.

Tanamoto K. , Galanos C. , Lüderitz O. , Kusumoto S. , Shiba T. Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A. Infect Immun 1984; 44: 427—433.

13.

Katschinski T. , Galanos C. , Coumbos A. , Freudenberg MA Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun 1992; 60: 1994—2001.

14.

Freudenberg MA , Kumazawa Y. , Meding S. , Langhorne J. , Galanos C. Gamma interferon production in endotoxin-responder and non-responder mice during infection. Infect Immun 1991; 59: 3484—3491.

15.

Lehmann V. , Freudenberg MA , Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in D-galactosamine-treated mice. J Exp Med 1987; 165: 657—663.

16.

Freudenberg MA , Gumenscheimer M. , Jack R. , Merlin T. , Schütt C. , Galanos C. A strict requirement for LBP in TNF-α hyper-response of Propionibacterium acnes-sensitized mice to LPS. J Endotoxin Res 1997; 4: 357—361.